XML 29 R12.htm IDEA: XBRL DOCUMENT

GOODWILL AND OTHER INTANGIBLE ASSETS, NET

12 Months Ended

Dec. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND OTHER INTANGIBLE ASSETS, NET

5. GOODWILL AND OTHER INTANGIBLE ASSETS, NET

During 2015, we did not record any goodwill impairment charges as a result of our annual impairment test and none of the goodwill associated with our various reporting units were considered at risk of impairment as of October 31, 2015. Since the date of our last annual goodwill impairment test, there have been no material developments, events, changes in operating performance or other circumstances that would cause management to believe it is more likely than not that the fair value of any of our reporting units would be less than its carrying amount.

During the fiscal year 2014, we recognized a non-cash other intangible impairment charge of $0.9 million during step one of our 2014 annual goodwill impairment test. In addition, we recorded non-cash impairment charges of $2.2 million related to those care centers that were closed or consolidated during 2014 as discussed in Note 13 – Exit and Restructuring Activities.

During the fiscal year 2013, we recognized the following: a non-cash goodwill impairment charge of $1.3 million and a non-cash other intangibles impairment charge of $8.2 million. The non-cash goodwill impairment charge related to an investment that was consolidated as discussed in Note 1- Nature of Operations, Consolidation and Presentation of Financial Statements. Included in the non-cash other intangibles impairment charge discussed above is $4.6 million recognized during step one of our 2013 annual goodwill impairment test and $3.6 million related to intangibles associated with those care centers that were closed or consolidated during 2013 as discussed in Note 13 – Exit and Restructuring Activities.

The following table summarizes the activity related to our goodwill for the 2015, 2014 and 2013 (amounts in millions):

		Goodwill
		Home Health		Hospice		Total
Balances at December 31, 2012		$	18.2	$	191.4	$	209.6
	Additions		0.1		0.9		1.0
	Write-off (1)		(0.4)		0.0		(0.4)
	Impairment		(1.3)		0.0		(1.3)
Balances at December 31, 2013			16.6		192.3		208.9
	Write-off (1)		(0.1)		(3.2)		(3.3)
Balances at December 31, 2014			16.5		189.1		205.6
	Additions		50.6		5.5		56.1
Balances at December 31, 2015		$	67.1	$	194.6	$	261.7

Write-off of goodwill related to the sale of care centers as discussed in Note 13 – Exit and Restructuring Activities.

The following table summarizes the activity related to our other intangible assets, net for 2015, 2014 and 2013 (amounts in millions):

		Other Intangible Assets, Net
						Non-Compete
						Agreements &
		Certificates of		Acquired		Reacquired
		Need and		Names of		Franchise
		Licenses		Business		Rights		Total
Balances at December 31, 2012		$	33.7	$	11.5	$	1.8	$	47.0
	Additions		0.6		0.0		0.0		0.6
	Write-off (1)		(1.1)		0.0		0.0		(1.1)
	Impairment		(7.8)		(0.4)		0.0		(8.2)
	Amortization		0.0		0.0		(1.6)		(1.6)
Balances at December 31, 2013			25.4		11.1		0.2		36.7
	Write-off (1)		(0.2)		0.0		0.0		(0.2)
	Impairment		(2.1)		(1.0)		0.0		(3.1)
	Amortization		0.0		0.0		(0.2)		(0.2)
Balances at December 31, 2014			23.1		10.1		0.0		33.2
	Additions		1.1		4.1		5.9		11.1
	Write-off (1)		(0.3)		0.0		0.0		(0.3)
Balances at December 31, 2015		$	23.9	$	14.2	$	5.9	$	44.0

Write-off of intangible assets related to the sale of care centers as discussed in Note 13 – Exit and Restructuring Activities.
The weighted average amortization period of our non-compete agreements is 3.0 years.

See Note 3 – Acquisitions for further details on additions to goodwill and other intangible assets, net.

The estimated aggregate amortization expense for each of the five succeeding years is as follows (amounts in millions):

	2016	$	2.0
	2017		2.0
	2018		1.9
	2019		0.0
	2020		0.0
		$	5.9

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details